While weight loss is a common new year’s resolution for workers in the U.S., 2025 may mark the year that building weight loss benefits becomes a resolution for employers.
According to KFF, just 18% of companies with 200 or more employees cover GLP-1 drugs, a class of medications that reduce blood sugar levels and regulate appetite. Given that these drugs cost $700 to $1,400 a month without insurance, they can pose a financial hardship for employers and employees alike. However, more companies may consider adding coverage despite the costs in hopes of helping employees prevent and manage chronic conditions like obesity and diabetes.
